Growth and EGFR regulation in breast cancer cells by vitamin D and retinoid compounds

Breast Cancer Research and Treatment

Volumn 86, Issue 1, 2004, Pages 55-73

  McGaffin, Kenneth R ^a,b   Acktinson, Lisa E ^c   Chrysogelos, Susan A ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

breast cancer; EGFR; retinoids; transcription; vitamin D

Indexed keywords

ALITRETINOIN; CALCITRIOL DERIVATIVE; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; RETINOIC ACID; RETINOID DERIVATIVE; VITAMIN D;

ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL STRAIN MCF 7; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; GEL MOBILITY SHIFT ASSAY; HALF LIFE TIME; HUMAN; HUMAN CELL; MEASUREMENT; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE;

BREAST NEOPLASMS; CELL DIVISION; DOWN-REGULATION; GENES, REPORTER; HUMANS; PLASMIDS; PROMOTER REGIONS (GENETICS); RECEPTOR, EPIDERMAL GROWTH FACTOR; RETINOIDS; RNA, MESSENGER; TRANSCRIPTION, GENETIC; TRANSFECTION; TUMOR CELLS, CULTURED; VITAMIN D;

EID: 3142699193     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:BREA.0000032923.66250.92     Document Type: Article

References (68)

1. Rajkumar T, Gullick WJ: The type I growth factor receptors in human breast cancer. Breast Cancer Res Treat 29: 3-9, 1994
2. Buras RR, Schumaker LM, Davoodi F, Brenner RV, Shabahang M, Nauta RJ, Evans SR: Vitamin D receptors in breast cancer cells. Breast Cancer Res Treat 31: 191-202, 1994
3. Looi LM, Cheah PL: C-erbB-2 oncoprotein amplification in infiltrating ductal carcinoma of the breast relates to high histological grade and loss of estrogen receptor protein. Malays J Pathol 20: 19-23, 1998
4. Harris AL: What is the biological, prognostic, and therapeutic role of the EGF receptor in human breast cancer? Breast Cancer Res Treat 29: 1-2, 1994
5. Sainsbury J, Farndon J, Needham G, Malcolm A, Harris A: Epidermal growth factor receptor status as a predictor of early recurrence of and death from breast cancer. Lancet I: 1398-1402, 1987
6. Chrysogelos SA, Dickson RB: EGF receptor expression, regulation, and function in breast cancer. Breast Cancer Res Treat 29: 29-40, 1994
7. Ulrich A, Schlessinger J: Signal transduction by receptors with tyrosine kinase activity. Cell 61: 203-212, 1990
8. Jardines L, Weiss M, Fowble B, Green M: Neu(c-erbB-2/HER2) and the epidermal growth factor receptor (EGFR) in breast cancer. Pathobiology 61: 268-282, 1993
9. Davidson NE, Gelmann EP, Lipmann ME, Dickson RB: Epidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell lines. Mol Endocrinol 1: 216-223, 1987
10. DiFiore P, Pierce J, Fleming T, Hazon R, Ulrich A, King CR, Schlessinger J, Aaronson S: Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH3T3 cells. Cell 51: 1063-1070, 1987
11. Liu YE, Lupu R, Kern FG: Characterization of MCF7 breast carcinoma cells singly or doubly transfected with c-erbB2 and EGFR. Proc AARC 33: 368, 1992
12. Agthoven TV, Agthoven TLAV, Portengen H, Foekers JA, Dorsse LCJ: Ectopic expression of epidermal growth factor receptors induces hormone independence in ZR-75-1 human breast cancer cells. Cancer Res 52: 5082-5088, 1992
13. Baselga J, Medelsohn J: The epidermal growth factor receptor as a target for therapy in breast carcinoma. Breast Cancer Res Treat 29: 157-138, 1994
14. Clark AJL, Ishii S, Richert N, Merlino GT, Pastan I: Epidermal growth factor regulates the expression of its own receptor. Proc Natl Acad Sci USA 82: 8374-8378, 1985
15. Desprez PY, Poujol D, Falette N, Lefebvre NF, Saez S: 1,25-dihydroxyvitamin D3 increases epidermal growth factor gene expression in BT-20 breast carcinoma cells. Biochem Biophys Res Comm 176: 1-6, 1991
16. Prasad KN, Edwards-Prasad J, Kumar S, Meyers A: Vitamins regulate gene expression and induce differentiation and growth ainhibition in cancer cells. Their relevance in cancer prevention. Arch Otolaryngol Head Neck Surg 119: 1133-1140, 1993
17. Welsh J, VanWeelden K, Flanagan L, Byrne I, Nolan E, Narvaez CJ: The role of vitamin D3 and antiestrogens in modulating apoptosis of breast cancer cells and tumors. Subcell Biochem 30: 245-270, 1998
18. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfiled AE: 1 alpha,25-dihydroxyvitamin D3 inhibits angiogenesis in vitro and in vivo. Circ Res 87: 214-220, 2000
19. Hansen CM, Frandsen TL, Brunner N, Binderup L: 1 alpha,25- dihydroxyvitamin D3 inhibits the invasive potential of human breast cancer cells in vitro. Clin Exp Metastasis 12: 195-202, 1994
20. Chouvet C, Vicard E, Devonec M, Saez S: 1,25-dihydroxyvitamin D3 inhibitory effect on the growth of two human breast cancer cell lines (MCF7, BT-20). J Steroid Biochem 24: 373-376, 1986
21. Koga M, Sutherland RL: Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation. J Steroid Biochem Mol Biol 39: 455-460, 1991
22. Zheng ZS, Polakowska R, Johnson A, Goldsmith LA: Transcriptional control of epidermal growth factor receptor by retinoic acid. Cell Grow Diff 3: 255-232, 1992
23. Chomczynski P, Sacchi N: Single step method of RNA isolation by acid guanidinium thiocyanate-pheno-chloroform extraction. Anal Biochem 162: 156-159, 1987
24. Laborda J: 36B4 cDNA used as an estradiol-independent mRNA control is the cDNA for human acidic ribosomal phosphoprotein PO. Nucl Acids Res 19: 3998, 1991
25. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 72: 248-254, 1976
26. Salinovich O, Montelaro RC: Reversible staining and peptide mapping of proteins transferred to nitrocellulose after separation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Analytical Biochem 156: 341-347, 1986
27. Dignam JD, Lebovitz RM, Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl Acids Res 11: 1475-1489, 1983
28. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM: The nuclear receptor superfamily: the second decade. Cell 83: 835-839, 1995
29. Roman SD, Clarke CL, Hall RE, Alexander IE, Sutherland RL: Expression and regulation of retinoic acid receptors in human breast cancer cells. Cancer Res 52: 2236-2242, 1992
30. Shao ZM, Sheikh MS, Chen JC, Kute T, Aisner S, Schnaper L, Fontana JA: Expression of the retinoic acid nuclear receptors (RARs) and retinoid X receptor genes in estrogen receptor positive and negative breast cancer. Int J Oncol 4: 859-8563, 1994
31. Zhou JY, Norman AW, Akashi M, Chen DL, Uskokovic MR, Aurrecoehea JM, Dauben WG, Okamura WH, Koeffler HP: Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism. Blood 78: 75-82, 1991
32. 3-activated expression of the rat osteocalcin gene. Mol Cell Biol 13: 5907-5917, 1993
33. DeLuca HF, Zierold C: Mechanisms and functions of vitamin D. Nutr Rev 56: S54-S75, 1998
34. Fridovich-Keil JL, Gudas JM, Bryan IB, Pardee AB: Improved expression vectors for eukaryotic promoter/enhancer studies. BioTechniques 11: 572-579, 1991
35. Umesono K, Murakami KK, Thompson CC, Evans RM: Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell 65: 1255-1266, 1991
36. Ozono K, Liao J, Kerner SA, Scott RA, Pike JW: The vitamin D-responsive element in the human osteocalcin gene. J Biol Chem 265: 21881-21888, 1990
37. Demay MB, Gerardi JM, DeLuca HF, Kronenberg HM: DNA sequences in the rat osteocalcin gene that bind the 1,25-dihydroxyvitamin D3 receptor and confer responsiveness to 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA 87: 369-373, 1990
38. Noda M, Vogel RL, Craig AM, Prahl J, DeLuca HF, Denhardt DT: Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phospoprotein 1 (Spp-1 or osteopontin.). Proc Natl Acad Sci USA 87: 9995-9999, 1990
39. Lippman SM, Kessler JF, Meyskens FL: Retinoids as preventive and therapeutic anticancer agents (part 1). Cancer Treat Rep 71: 391-405, 1987
40. Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Rosner B, Hennekens CH, Speizer FE, Wilett WC: A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl J Med 329: 234-240, 1993
41. Blot WJ, Fraumeni JF, Stone BJ: Geographic patterns of breast cancer in the United States. JNCI 59: 1407-1411, 1977
42. Gorham ED, Garland CF, Garland FC: Acid haze air pollution in breast and colon cancer mortality in 20 Canadian cities. Can J Public Health 80: 96-100, 1989
43. Garland FC, Garland CF, Gorham ED, Young JF: Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med 19: 614-622, 1990
44. Gorham ED, Garland FC, Garland CF: Sunlight and breast cancer incidence in the USSR. Int J Epidemiol 19: 820-824, 1990
45. Garland FC, Garland CF, Gorham ED: Calcium and vitamin D: their potential roles in colon and breast cancer prevention. Ann NY Acad Sci 889: 107-119, 1999
46. Haddad JG, Hahn TJ: Natural and synthetic sources of circulating 25-hydroxyvitamin D in man. Nature 244: 515-517, 1973
47. Janowsky EC, Lester GE, Weinberg CR, Millikan RC, Schildkraut JM, Garrett PA, Hulka BS: Association between low levels of 1,25-dihydroxyvitamin D3 and breast cancer risk. Public Health Nutr 2: 283-291, 1999
48. Bower M, Colston KW, Stein RC, Hedley A, Gazet J-C, Ford HT, Coombes RC: Topical calcipotriol treatment in advanced breast cancer. Lancet 337: 701-702, 1991
49. Colston KW, Berger U, Coombes RC: Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1(8631): 188-191, 1989
50. Sheikh MS, Shao Z-M, Chen J-C, Hussain A, Jetten AM, Fontana JA: Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RARa gene expression and sensitivity to growth inhibition by retinoic acid. J Cell Biochem 53: 394-404, 1993
51. 3 receptor on growth-regulatory pathways in mammary gland and breast cancer. J Steroid Biochem Mol Biol 83: 85-92, 2003
52. 3 on breast cells - a mini review. Braz J Med Biol Res 35: 1-9, 2002
53. 3 in rat osteosarcoma cells: structure-function studies using ligand analogs. Endocrinology 129: 1876-1884, 1991
54. Nemere I, Norman AW: Steroid hormone actions at the plasma membrane: induced calcium uptake and exocytotic events. Mol Cell Endocrinol 80: C165-C169, 1991
55. 3 rapidly increases nuclear calcium levels in rat osteosarcoma cells. J Cell Biochem 52: 237-242, 1993
56. 3 metabolites on cytosolic free calcium in confluent mouse osteoblasts. J Biol Chem 262: 13168-13173, 1987
57. Grosse B, Bourdeau A, Lieberherr M: Oscillation in inositiol 1,4,5-triphosphate and diacylglycerol induced by vitamin D metabolites in confluent mouse osteoblasts. Bone Min Res 8: 1059-1069, 1993
58. 3-induced changes in intracellular pH in osteoblast-like cells modulate gene expression. J Cell Biochem 53: 234-239, 1993
59. Laird AD, Shalloway D: Oncoprotein signalling and mitosis. Cell Signal 9: 249-255, 1997
60. Codero JB, Cozzolino M, Lu Y, Vidal M, Slatopolsky E, Stahl P, Barbieri MA, Dusso A: 1,25-dihydroxyvitamin D downregulates cell membrane growth and nuclear-growth promoting signals by the epidermal growth factor receptor. J Biol Chem 277: 38965-38971, 2002
61. Koga M, Eisman JA, Sutherland RL: Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin D3 in human breast cancer cells. Cancer Res 48: 2734-2739, 1988
62. Falette N, Frappart L, Lefebvre MF, Saez S: Increased epidermal growth factor receptor level in breast cancer cells treated by 1,25-dihydroxyvitamin D3. Mol Cell Endo 63: 189-198, 1989
63. Yarden RI, Wilson MA, Barth M, Chrysogelos SA: The role of estrogen in the regulation of EGFR expression. In: Lichtner RB, Harkins RN (eds) Ernest Schering Research Foundation Workshop 19: EGF Receptor in Tumor Growth and Progression. Springer Scientific Publishers, Berlin, 1996, pp 129-154
64. Pike JW: Vitamin D3 receptors: structure and function in transcription. Annu Rev Nutr 11: 189-216, 1991
65. Gonzales EA, Disthabanchong S, Kowalewski R, Martin K: Mechanisms of regulation of egf receptor gene expression by calcitriol and parathyroid hormone in UMR 106-01 cells. Kidney Int 61: 1627-1634, 2002
66. Haley J, Whittle N, Bennet P, Kinchington D, Ulrich A, Waterfield M: The human egf receptor gene: structure of the 110kb locus and identification of sequences regulating its transcription. Oncogene Res 1: 375-396, 1987
67. Johnson AC, Ishii S, Jinno Y, Pastan I, Merlino GT: Epidermal growth factor gene promoter. Deletion analysis and identification of nuclear protein binding sites. J Biol Chem 263: 5693-5699, 1988
68. Kageyama R, Pastan I: Molecular cloning and characterization of a human DNA binding factor that represses transcription. Cell 59: 815-825, 1989